|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/10 | |
| A61K 38/13 | |||
| A61K 47/32 | |||
| A61K 47/36 | |||
| A61K 47/38 | |||
| C07K 1/30 | |||
| C07K 7/64 |
| (11) | Number of the document | 2779992 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12788092.0 |
| Date of filing the European patent application | 2012-11-14 | |
| (97) | Date of publication of the European application | 2014-09-24 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/064988 |
| Date | 2012-11-14 |
| (87) | Number | WO 2013/074610 |
| Date | 2013-05-23 |
| (30) | Number | Date | Country code |
| 201161559838 P | 2011-11-15 | US | |
| 201161563199 P | 2011-11-23 | US |
| (72) |
BLANDA, Wendy M., US
ATTAR, Mayssa, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2 |
| SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2 |